Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AVITA Medical Q2 EPS $(0.38) Misses $(0.25) Estimate, Sales $18.42M Miss $22.61M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:09pm
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.25) by 53.23 percent. This is a 36.67 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $18.42 million which missed the analyst consensus estimate of $22.61 million by 18.54 percent. This is a 21.21 percent increase over sales of $15.20 million the same period last year.

Posted In: RCEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist